Bowel cancer, also known as colorectal cancer, is the fourth most commonly diagnosed cancer and the second leading cause of cancer-related deaths in Australia. It can affect individuals of all ages, with an increasing prevalence among younger populations in recent years. Early detection is crucial, as it significantly increases the likelihood of successful treatment and cure.
Treatment for bowel cancer often involves surgery to remove a portion of the colon or rectum, depending on the cancer’s location. In some cases, chemotherapy or immunotherapy may be required as part of the treatment plan. For patients with rectal cancer, radiotherapy may also be offered.
Dr Petrushnko tailors his treatment plan to each individual patient. He is also a member of the Multidisciplinary Cancer Team (MDT).
Current recommendations for bowel cancer screening using the iFOBT (immunochemical fecal occult blood test) target asymptomatic individuals aged 45–74. Screening is also available for asymptomatic individuals aged 40–44 after consultation with a health care professional regarding harm and benefits of screening. Bowel cancer screening is offered every two years.
Screening intervals may change if polyps or tumors are detected. Patients with a family history of bowel cancer may require more frequent colonoscopy screenings at intervals determined by their healthcare provider.
If you receive a positive bowel cancer screening test result, it is essential to follow up with a colonoscopy for further evaluation.
Note: Bowel cancer screening is intended for asymptomatic individuals. If you experience any symptoms, you should seek prompt medical attention for further investigation.
Symptoms
